Observational study reveals higher risk of recurrent transient motion during gadoxetate disodium MRI in prior-affected patients, indicating a persistent susceptibility to arterial phase artifacts.
Patients who experience TSM transient severe motion during gadoxetate disodium-enhanced MR imaging are at significantly and substantially higher risk for TSM transient severe motion in the next gadoxetate disodium-enhanced examination compared with patients who do not have TSM transient severe motion during their initial gadoxetate disodium administration.
No takes yet. Share an insight, caveat, or question.
Bashir et al. (2014) studied this question.